Purple Cell

Archives: Resources

PPD Inc | White Paper
Improved Risk Management: Benefits of Predefined Quality Tolerance Limits
  • External Link

PPD has established a robust and well-integrated, cross-functional process to help its sponsors
execute the QTL component of ICH E6 (R2).

Read More
PPD Inc | Brochure
Early Development and Clinical Pharmacology Solutions Brochure

PPD’s early development and clinical pharmacology solutions allow clients to maximize value in their early stage portfolios.

Read Brochure
PPD Inc | White Paper
Outsourcing Regulatory Lifecycle Management: Drivers, Challenges and Considerations
  • External Link

This paper discusses delegating responsibility for effective planning and delivery of lifecycle management of global marketing authorizations

Read More
PPD Inc | White Paper
Integrated Approach to Clinical Management and Central Lab Services
  • External Link

This paper explores PPD’s operating model, which incorporates lab strategy within the clinical development process.

Read More
PPD Inc | White Paper
Innovative Technology Provides Seamless Data Integration
  • External Link

This paper discusses efficiencies that can be achieved using an automated platform that integrates patient data and central laboratory data.

Read More
PPD Inc | eBook
Updating Research, Development and Regulatory Models for Gene Therapy
  • External Link

This e-book offers perspectives on how to ensure a smoother pathway to commercialization for cell and gene therapy.

Read More
PPD Inc | Resources
GMP Lab Publications on Inhaled Pharmaceuticals

Our GMP scientists have chosen a few of their presentations and publications to share with you.

Read More